GJ is a 79-year-old woman with hypertension, diabetes, osteoporosis, depression, and New York Heart Association class II heart failure with a left ventricular ejection fraction of 30%. She is a potential candidate for an implantable cardioverter-defibrillator (ICD), and you would like to discuss this with her using evidence from a clinical trial. Which of the following statistics would be most helpful in explaining the possible survival benefit of an ICD?
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023